How does the genome build the brain? Can the genome be used as a molecular tool to study brain development directly in humans? And can newly developed genomics technologies be deployed more rapidly and reliably in clinical medicine?
Our mission is to develop foundational new technologies to advance neuroscience and human genetics and to help solve diagnostic mysteries in neurology and psychiatry. We also aim to accelerate the implementation of genomics in clinical medicine, especially for children with rare undiagnosed diseases.
Adam Schwing (MSTP student) has passed his PhD qualifying exam!
Congratulations to Danielle on her acceptance to NYU Medical School!
We have launched the NYU Pediatric Undiagnosed Diseases Program. This program’s mission is to find diagnoses for children with rare genetic diseases.